Dubin Michael F 4
4 · Virpax Pharmaceuticals, Inc. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Dubin Michael F
Director
Transactions
- Award
Stock Option (right to buy)
2022-01-01+12,091→ 12,091 totalExercise: $3.43From: 2023-01-01Exp: 2032-01-01→ Common Stock (12,091 underlying)